EndoQuest Robotics manufactures a flexible robotic surgical system designed for endoluminal and single-incision procedures, allowing surgeries to be performed through natural orifices or a transumbilical incision. This technology minimizes external incisions, reduces patient trauma, and accelerates recovery, ultimately lowering healthcare costs.
Funding
$145.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CVMIFounders
Product
Problem
Traditional surgical procedures often require large external incisions to access the surgical site, leading to significant patient trauma, extended recovery times, and increased healthcare costs. Minimally invasive techniques, while an improvement, may still necessitate incisions through healthy tissue.
Solution
EndoQuest Robotics has developed a flexible robotic surgical system designed for endoluminal and single-incision procedures. This technology enables surgeons to perform operations through the body's natural orifices or a single transumbilical incision, eliminating or minimizing the need for external incisions. By accessing the surgical site through these natural pathways, the system aims to reduce patient trauma, accelerate recovery, and improve overall patient outcomes. The system enhances physician capabilities by providing greater precision and control during complex procedures, ultimately redefining the landscape of minimally invasive surgery.
Target Audience
The primary target audience includes surgeons and hospitals seeking to adopt advanced minimally invasive surgical techniques that reduce patient trauma and improve outcomes.
Features
- Flexible robotic platform designed for endoluminal and single-incision access.
- Minimally invasive approach reduces the need for large external incisions.
- Enhanced surgical precision and control for complex procedures.
- Potential for reduced patient trauma and accelerated recovery times.